世界の脊椎腫瘍転移市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Metastases Spinal Tumor Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3732
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、脊椎腫瘍転移のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（外科的治療、薬物療法、放射線療法、アブレーション、その他）、用途別市場規模（病院・クリニック、外来手術センター、学術機関、研究センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・脊椎腫瘍転移の市場動向
・企業の競争状況、市場シェア
・脊椎腫瘍転移の種類別市場規模（外科的治療、薬物療法、放射線療法、アブレーション、その他）
・脊椎腫瘍転移の用途別市場規模（病院・クリニック、外来手術センター、学術機関、研究センター、その他）
・脊椎腫瘍転移の北米市場規模2016-2027（アメリカ、カナダ）
・脊椎腫瘍転移のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・脊椎腫瘍転移のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・脊椎腫瘍転移の中南米市場規模2016-2027（メキシコ、ブラジル）
・脊椎腫瘍転移の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Roche、Amgen、Novartis、Abbott、Beckman Coulter、Debiopharm Group、AbbVie、Bayer）
・結論

A spine tumor is an abnormal growth of tissue found in and/or around the spinal column and/or spinal cord. More than 95% of all metastatic spinal tumors are found outside the dura (extradural) and within the vertebral body, and in more than half of the cases they are found on multiple levels of the spine.
It is common for cancer cells to metastasize, or spread, to bones. Most commonly, cancer cells spread to the lung, the liver, and the bones, respectively, and most bone metastases occur in the spine. The most common way for cancer cells to reach the spine is via the blood stream, after which they enter the bone marrow and begin to multiply.

Market Analysis and Insights: Global Metastases Spinal Tumor Market
The global Metastases Spinal Tumor market size is projected to reach US$ 1373.7 million by 2026, from US$ 1209.5 million in 2019, at a CAGR of 1.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metastases Spinal Tumor market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metastases Spinal Tumor market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metastases Spinal Tumor market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metastases Spinal Tumor market.

Global Metastases Spinal Tumor Scope and Market Size
Metastases Spinal Tumor market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metastases Spinal Tumor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
by Treatment
Surgical Treatment
Medications
Radiation Therapy
Ablation
Others
by Diagnosis
Laboratory Tests
Imaging Tests
Biopsy
Others

Segment by Application
Hospital & Clinics
Ambulatory Surgery Centers
Academic Institutes
Research Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
Amgen
Novartis
Abbott
Beckman Coulter
Debiopharm Group
AbbVie
Bayer

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metastases Spinal Tumor Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgical Treatment
1.2.3 Medications
1.2.4 Radiation Therapy
1.2.5 Ablation
1.2.6 Others
1.3 Market by Application
1.3.1 Global Metastases Spinal Tumor Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital & Clinics
1.3.3 Ambulatory Surgery Centers
1.3.4 Academic Institutes
1.3.5 Research Centers
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Metastases Spinal Tumor Market Perspective (2016-2027)
2.2 Metastases Spinal Tumor Growth Trends by Regions
2.2.1 Metastases Spinal Tumor Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Metastases Spinal Tumor Historic Market Share by Regions (2016-2021)
2.2.3 Metastases Spinal Tumor Forecasted Market Size by Regions (2022-2027)
2.3 Metastases Spinal Tumor Industry Dynamic
2.3.1 Metastases Spinal Tumor Market Trends
2.3.2 Metastases Spinal Tumor Market Drivers
2.3.3 Metastases Spinal Tumor Market Challenges
2.3.4 Metastases Spinal Tumor Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Metastases Spinal Tumor Players by Revenue
3.1.1 Global Top Metastases Spinal Tumor Players by Revenue (2016-2021)
3.1.2 Global Metastases Spinal Tumor Revenue Market Share by Players (2016-2021)
3.2 Global Metastases Spinal Tumor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Metastases Spinal Tumor Revenue
3.4 Global Metastases Spinal Tumor Market Concentration Ratio
3.4.1 Global Metastases Spinal Tumor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metastases Spinal Tumor Revenue in 2020
3.5 Metastases Spinal Tumor Key Players Head office and Area Served
3.6 Key Players Metastases Spinal Tumor Product Solution and Service
3.7 Date of Enter into Metastases Spinal Tumor Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Metastases Spinal Tumor Breakdown Data by Type
4.1 Global Metastases Spinal Tumor Historic Market Size by Type (2016-2021)
4.2 Global Metastases Spinal Tumor Forecasted Market Size by Type (2022-2027)

5 Metastases Spinal Tumor Breakdown Data by Application
5.1 Global Metastases Spinal Tumor Historic Market Size by Application (2016-2021)
5.2 Global Metastases Spinal Tumor Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Metastases Spinal Tumor Market Size (2016-2027)
6.2 North America Metastases Spinal Tumor Market Size by Type
6.2.1 North America Metastases Spinal Tumor Market Size by Type (2016-2021)
6.2.2 North America Metastases Spinal Tumor Market Size by Type (2022-2027)
6.2.3 North America Metastases Spinal Tumor Market Size by Type (2016-2027)
6.3 North America Metastases Spinal Tumor Market Size by Application
6.3.1 North America Metastases Spinal Tumor Market Size by Application (2016-2021)
6.3.2 North America Metastases Spinal Tumor Market Size by Application (2022-2027)
6.3.3 North America Metastases Spinal Tumor Market Size by Application (2016-2027)
6.4 North America Metastases Spinal Tumor Market Size by Country
6.4.1 North America Metastases Spinal Tumor Market Size by Country (2016-2021)
6.4.2 North America Metastases Spinal Tumor Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Metastases Spinal Tumor Market Size (2016-2027)
7.2 Europe Metastases Spinal Tumor Market Size by Type
7.2.1 Europe Metastases Spinal Tumor Market Size by Type (2016-2021)
7.2.2 Europe Metastases Spinal Tumor Market Size by Type (2022-2027)
7.2.3 Europe Metastases Spinal Tumor Market Size by Type (2016-2027)
7.3 Europe Metastases Spinal Tumor Market Size by Application
7.3.1 Europe Metastases Spinal Tumor Market Size by Application (2016-2021)
7.3.2 Europe Metastases Spinal Tumor Market Size by Application (2022-2027)
7.3.3 Europe Metastases Spinal Tumor Market Size by Application (2016-2027)
7.4 Europe Metastases Spinal Tumor Market Size by Country
7.4.1 Europe Metastases Spinal Tumor Market Size by Country (2016-2021)
7.4.2 Europe Metastases Spinal Tumor Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Metastases Spinal Tumor Market Size (2016-2027)
8.2 Asia-Pacific Metastases Spinal Tumor Market Size by Type
8.2.1 Asia-Pacific Metastases Spinal Tumor Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Metastases Spinal Tumor Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Metastases Spinal Tumor Market Size by Type (2016-2027)
8.3 Asia-Pacific Metastases Spinal Tumor Market Size by Application
8.3.1 Asia-Pacific Metastases Spinal Tumor Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Metastases Spinal Tumor Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Metastases Spinal Tumor Market Size by Application (2016-2027)
8.4 Asia-Pacific Metastases Spinal Tumor Market Size by Region
8.4.1 Asia-Pacific Metastases Spinal Tumor Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Metastases Spinal Tumor Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Metastases Spinal Tumor Market Size (2016-2027)
9.2 Latin America Metastases Spinal Tumor Market Size by Type
9.2.1 Latin America Metastases Spinal Tumor Market Size by Type (2016-2021)
9.2.2 Latin America Metastases Spinal Tumor Market Size by Type (2022-2027)
9.2.3 Latin America Metastases Spinal Tumor Market Size by Type (2016-2027)
9.3 Latin America Metastases Spinal Tumor Market Size by Application
9.3.1 Latin America Metastases Spinal Tumor Market Size by Application (2016-2021)
9.3.2 Latin America Metastases Spinal Tumor Market Size by Application (2022-2027)
9.3.3 Latin America Metastases Spinal Tumor Market Size by Application (2016-2027)
9.4 Latin America Metastases Spinal Tumor Market Size by Country
9.4.1 Latin America Metastases Spinal Tumor Market Size by Country (2016-2021)
9.4.2 Latin America Metastases Spinal Tumor Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Metastases Spinal Tumor Market Size (2016-2027)
10.2 Middle East & Africa Metastases Spinal Tumor Market Size by Type
10.2.1 Middle East & Africa Metastases Spinal Tumor Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Metastases Spinal Tumor Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Metastases Spinal Tumor Market Size by Type (2016-2027)
10.3 Middle East & Africa Metastases Spinal Tumor Market Size by Application
10.3.1 Middle East & Africa Metastases Spinal Tumor Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Metastases Spinal Tumor Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Metastases Spinal Tumor Market Size by Application (2016-2027)
10.4 Middle East & Africa Metastases Spinal Tumor Market Size by Country
10.4.1 Middle East & Africa Metastases Spinal Tumor Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Metastases Spinal Tumor Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Metastases Spinal Tumor Introduction
11.1.4 Roche Revenue in Metastases Spinal Tumor Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Metastases Spinal Tumor Introduction
11.2.4 Amgen Revenue in Metastases Spinal Tumor Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Metastases Spinal Tumor Introduction
11.3.4 Novartis Revenue in Metastases Spinal Tumor Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Abbott Business Overview
11.4.3 Abbott Metastases Spinal Tumor Introduction
11.4.4 Abbott Revenue in Metastases Spinal Tumor Business (2016-2021)
11.4.5 Abbott Recent Development
11.5 Beckman Coulter
11.5.1 Beckman Coulter Company Details
11.5.2 Beckman Coulter Business Overview
11.5.3 Beckman Coulter Metastases Spinal Tumor Introduction
11.5.4 Beckman Coulter Revenue in Metastases Spinal Tumor Business (2016-2021)
11.5.5 Beckman Coulter Recent Development
11.6 Debiopharm Group
11.6.1 Debiopharm Group Company Details
11.6.2 Debiopharm Group Business Overview
11.6.3 Debiopharm Group Metastases Spinal Tumor Introduction
11.6.4 Debiopharm Group Revenue in Metastases Spinal Tumor Business (2016-2021)
11.6.5 Debiopharm Group Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Metastases Spinal Tumor Introduction
11.7.4 AbbVie Revenue in Metastases Spinal Tumor Business (2016-2021)
11.7.5 AbbVie Recent Development
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Bayer Business Overview
11.8.3 Bayer Metastases Spinal Tumor Introduction
11.8.4 Bayer Revenue in Metastases Spinal Tumor Business (2016-2021)
11.8.5 Bayer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Metastases Spinal Tumor Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgical Treatment
Table 3. Key Players of Medications
Table 4. Key Players of Radiation Therapy
Table 5. Key Players of Ablation
Table 6. Key Players of Others
Table 7. Global Metastases Spinal Tumor Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Metastases Spinal Tumor Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Metastases Spinal Tumor Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Metastases Spinal Tumor Market Share by Regions (2016-2021)
Table 11. Global Metastases Spinal Tumor Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Metastases Spinal Tumor Market Share by Regions (2022-2027)
Table 13. Metastases Spinal Tumor Market Trends
Table 14. Metastases Spinal Tumor Market Drivers
Table 15. Metastases Spinal Tumor Market Challenges
Table 16. Metastases Spinal Tumor Market Restraints
Table 17. Global Metastases Spinal Tumor Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Metastases Spinal Tumor Market Share by Players (2016-2021)
Table 19. Global Top Metastases Spinal Tumor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastases Spinal Tumor as of 2020)
Table 20. Ranking of Global Top Metastases Spinal Tumor Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Metastases Spinal Tumor Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Metastases Spinal Tumor Product Solution and Service
Table 24. Date of Enter into Metastases Spinal Tumor Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Metastases Spinal Tumor Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Metastases Spinal Tumor Revenue Market Share by Type (2016-2021)
Table 28. Global Metastases Spinal Tumor Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Metastases Spinal Tumor Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Metastases Spinal Tumor Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Metastases Spinal Tumor Revenue Market Share by Application (2016-2021)
Table 32. Global Metastases Spinal Tumor Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Metastases Spinal Tumor Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Metastases Spinal Tumor Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Metastases Spinal Tumor Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Metastases Spinal Tumor Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Metastases Spinal Tumor Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Metastases Spinal Tumor Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Metastases Spinal Tumor Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Metastases Spinal Tumor Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Metastases Spinal Tumor Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Metastases Spinal Tumor Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Metastases Spinal Tumor Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Metastases Spinal Tumor Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Metastases Spinal Tumor Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Metastases Spinal Tumor Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Metastases Spinal Tumor Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Metastases Spinal Tumor Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Metastases Spinal Tumor Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Metastases Spinal Tumor Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Metastases Spinal Tumor Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Metastases Spinal Tumor Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Metastases Spinal Tumor Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Metastases Spinal Tumor Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Metastases Spinal Tumor Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Metastases Spinal Tumor Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Metastases Spinal Tumor Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Metastases Spinal Tumor Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Metastases Spinal Tumor Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Metastases Spinal Tumor Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Metastases Spinal Tumor Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Metastases Spinal Tumor Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Metastases Spinal Tumor Market Size by Country (2022-2027) & (US$ Million)
Table 64. Roche Company Details
Table 65. Roche Business Overview
Table 66. Roche Metastases Spinal Tumor Product
Table 67. Roche Revenue in Metastases Spinal Tumor Business (2016-2021) & (US$ Million)
Table 68. Roche Recent Development
Table 69. Amgen Company Details
Table 70. Amgen Business Overview
Table 71. Amgen Metastases Spinal Tumor Product
Table 72. Amgen Revenue in Metastases Spinal Tumor Business (2016-2021) & (US$ Million)
Table 73. Amgen Recent Development
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Metastases Spinal Tumor Product
Table 77. Novartis Revenue in Metastases Spinal Tumor Business (2016-2021) & (US$ Million)
Table 78. Novartis Recent Development
Table 79. Abbott Company Details
Table 80. Abbott Business Overview
Table 81. Abbott Metastases Spinal Tumor Product
Table 82. Abbott Revenue in Metastases Spinal Tumor Business (2016-2021) & (US$ Million)
Table 83. Abbott Recent Development
Table 84. Beckman Coulter Company Details
Table 85. Beckman Coulter Business Overview
Table 86. Beckman Coulter Metastases Spinal Tumor Product
Table 87. Beckman Coulter Revenue in Metastases Spinal Tumor Business (2016-2021) & (US$ Million)
Table 88. Beckman Coulter Recent Development
Table 89. Debiopharm Group Company Details
Table 90. Debiopharm Group Business Overview
Table 91. Debiopharm Group Metastases Spinal Tumor Product
Table 92. Debiopharm Group Revenue in Metastases Spinal Tumor Business (2016-2021) & (US$ Million)
Table 93. Debiopharm Group Recent Development
Table 94. AbbVie Company Details
Table 95. AbbVie Business Overview
Table 96. AbbVie Metastases Spinal Tumor Product
Table 97. AbbVie Revenue in Metastases Spinal Tumor Business (2016-2021) & (US$ Million)
Table 98. AbbVie Recent Development
Table 99. Bayer Company Details
Table 100. Bayer Business Overview
Table 101. Bayer Revenue in Metastases Spinal Tumor Business (2016-2021) & (US$ Million)
Table 102. Bayer Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metastases Spinal Tumor Market Share by Type: 2020 VS 2027
Figure 2. Surgical Treatment Features
Figure 3. Medications Features
Figure 4. Radiation Therapy Features
Figure 5. Ablation Features
Figure 6. Others Features
Figure 7. Global Metastases Spinal Tumor Market Share by Application: 2020 VS 2027
Figure 8. Hospital & Clinics Case Studies
Figure 9. Ambulatory Surgery Centers Case Studies
Figure 10. Academic Institutes Case Studies
Figure 11. Research Centers Case Studies
Figure 12. Others Case Studies
Figure 13. Metastases Spinal Tumor Report Years Considered
Figure 14. Global Metastases Spinal Tumor Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Metastases Spinal Tumor Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Metastases Spinal Tumor Market Share by Regions: 2020 VS 2027
Figure 17. Global Metastases Spinal Tumor Market Share by Regions (2022-2027)
Figure 18. Global Metastases Spinal Tumor Market Share by Players in 2020
Figure 19. Global Top Metastases Spinal Tumor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastases Spinal Tumor as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Metastases Spinal Tumor Revenue in 2020
Figure 21. Global Metastases Spinal Tumor Revenue Market Share by Type (2016-2021)
Figure 22. Global Metastases Spinal Tumor Revenue Market Share by Type (2022-2027)
Figure 23. North America Metastases Spinal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Metastases Spinal Tumor Market Share by Type (2016-2027)
Figure 25. North America Metastases Spinal Tumor Market Share by Application (2016-2027)
Figure 26. North America Metastases Spinal Tumor Market Share by Country (2016-2027)
Figure 27. United States Metastases Spinal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Metastases Spinal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Metastases Spinal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Metastases Spinal Tumor Market Share by Type (2016-2027)
Figure 31. Europe Metastases Spinal Tumor Market Share by Application (2016-2027)
Figure 32. Europe Metastases Spinal Tumor Market Share by Country (2016-2027)
Figure 33. Germany Metastases Spinal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Metastases Spinal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Metastases Spinal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Metastases Spinal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Metastases Spinal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Metastases Spinal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Metastases Spinal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Metastases Spinal Tumor Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Metastases Spinal Tumor Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Metastases Spinal Tumor Market Share by Region (2016-2027)
Figure 43. China Metastases Spinal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Metastases Spinal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Metastases Spinal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Metastases Spinal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Metastases Spinal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Metastases Spinal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Metastases Spinal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Metastases Spinal Tumor Market Share by Type (2016-2027)
Figure 51. Latin America Metastases Spinal Tumor Market Share by Application (2016-2027)
Figure 52. Latin America Metastases Spinal Tumor Market Share by Country (2016-2027)
Figure 53. Mexico Metastases Spinal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Metastases Spinal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Metastases Spinal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Metastases Spinal Tumor Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Metastases Spinal Tumor Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Metastases Spinal Tumor Market Share by Country (2016-2027)
Figure 59. Turkey Metastases Spinal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Metastases Spinal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Metastases Spinal Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Roche Revenue Growth Rate in Metastases Spinal Tumor Business (2016-2021)
Figure 63. Amgen Revenue Growth Rate in Metastases Spinal Tumor Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Metastases Spinal Tumor Business (2016-2021)
Figure 65. Abbott Revenue Growth Rate in Metastases Spinal Tumor Business (2016-2021)
Figure 66. Beckman Coulter Revenue Growth Rate in Metastases Spinal Tumor Business (2016-2021)
Figure 67. Debiopharm Group Revenue Growth Rate in Metastases Spinal Tumor Business (2016-2021)
Figure 68. AbbVie Revenue Growth Rate in Metastases Spinal Tumor Business (2016-2021)
Figure 69. Bayer Revenue Growth Rate in Metastases Spinal Tumor Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界の脊椎腫瘍転移市場規模・現状・予測（2021年-2027年）

Global Metastases Spinal Tumor Market Size, Status and Forecast 2021-2027
QYR2104Z3732 2021年4月 94Pages
QYResearch社発行の本調査資料では、脊椎腫瘍転移のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（外科的治療、薬物療法、放射線療法、アブレーション、その他）、用途別市場規模（病院・クリニック、外来手術センター、学術機関、研究センター、その...

世界の脊髄性筋萎縮症治療市場規模・現状・予測（2021年-2027年）

Global Spinal Muscular Atrophy Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5404 2021年4月 94Pages
QYResearch社発行の本調査資料では、脊髄性筋萎縮症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、髄腔内）、用途別市場規模（SMAタイプ1、SMAタイプ2、SMAタイプ3、SMAタイプ4）、主要地域別市場規模（北米、アメリカ、...

世界の腫瘍治療フィールド市場規模・現状・予測（2021年-2027年）

Global Tumor Treating Fields (TTFields) Market Size, Status and Forecast 2021-2027
QYR2104Z5761 2021年4月 94Pages
QYResearch社発行の本調査資料では、腫瘍治療フィールドのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（低周波、中周波）、用途別市場規模（病院、診療所、がん・放射線治療センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界の交流電場腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Alternating Electric Field Tumor Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0261 2021年4月 96Pages
QYResearch社発行の本調査資料では、交流電場腫瘍治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（低周波、中周波）、用途別市場規模（病院、クリニック、がん・放射線治療センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、...

世界の脊髄性筋萎縮症市場規模・現状・予測（2021年-2027年）

Global Spinal Muscular Atrophy Market Size, Status and Forecast 2021-2027
QYR2104Z5403 2021年4月 91Pages
QYResearch社発行の本調査資料では、脊髄性筋萎縮症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（初期段階候補者、後期段階候補者）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界の変形性脊椎システム市場規模・現状・予測（2021年-2027年）

Global Deformity Spinal System Market Size, Status and Forecast 2021-2027
QYR2104Z1751 2021年4月 91Pages
QYResearch社発行の本調査資料では、変形性脊椎システムのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ロッド、フック、プレート、ケージ、ペディクルスクリュー）、用途別市場規模（病院、外来手術センター、その他）、主要地域別市場規模（北米、...

世界の脊髄刺激システム市場規模・現状・予測（2021年-2027年）

Global Spinal Cord Stimulation System Market Size, Status and Forecast 2021-2027
QYR2104Z5396 2021年4月 95Pages
QYResearch社発行の本調査資料では、脊髄刺激システムのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（従来脊髄刺激システム、高周波脊髄刺激システム、充電式脊髄刺激システム）、用途別市場規模（病院、理学療法センター、外来手術センター、クリニ...

世界の脊椎手術市場規模・現状・予測（2021年-2027年）

Global Spinal Surgery Market Size, Status and Forecast 2021-2027
QYR2104Z5406 2021年4月 91Pages
QYResearch社発行の本調査資料では、脊椎手術のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（顕微鏡、脊椎ブラケット、X線装置、その他）、用途別市場規模（病院、医療センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界の脊椎画像ガイダンスシステム市場規模・現状・予測（2021年-2027年）

Global Spinal Image Guidance Systems Market Size, Status and Forecast 2021-2027
QYR2104Z5399 2021年4月 90Pages
QYResearch社発行の本調査資料では、脊椎画像ガイダンスシステムのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（X線、磁気共鳴画像法（MRI）、コンピューター断層撮影（CT）、3D透視技術）、用途別市場規模（病院、外来手術センター、診断セ...

世界の消化管間質腫瘍市場規模・現状・予測（2021年-2027年）

Global Gastrointestinal Stromal Tumor Market Size, Status and Forecast 2021-2027
QYR2104Z2500 2021年4月 99Pages
QYResearch社発行の本調査資料では、消化管間質腫瘍のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（胃、小腸、その他）、用途別市場規模（病院、クリニック、専門がん治療センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界の脊椎腫瘍転移市場規模・現状・予測（2021年-2027年） A spine tumor is an abnormal growth of tissue found in and/or around the spinal column and/or spinal cord. More than 95% of all metastatic spinal tumors are found outside the dura (extradural) and within the vertebral body, and in more than half of the cases they are found on multiple levels of the …
世界の交流電場腫瘍治療市場規模・現状・予測（2021年-2027年） Alternating electric field tumor therapy is an anticancer treatment which disrupts the tumor cells mitosis. Alternating electric field therapy is a low intensity technique which disrupts the division of cells through physical interaction of molecules during mitosis in tumor cancer. The alternating e…
世界の脊髄性筋萎縮症（SMA）治療市場規模・現状・予測（2021年-2027年） Spinal muscular atrophy (SMA) refers to a group of inherited diseases that affects the functioning of muscles because of deterioration. North America dominates the global market for SMA treatment due to the high prevalence of SMA and increased adoption of SMA treatment options in the region. Market …
世界の腫瘍アブレーション＆インターベンショナルラジオロジー市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tumor Ablation and Interventional Radiology Market The global Tumor Ablation and Interventional Radiology market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …
世界の内視鏡的脊椎手術市場規模・現状・予測（2021年-2027年） Endoscope spinal surgery is a non-invasive process in which complex spinal surgery is done by use of an endoscope. Endoscopic spinal surgery market shows promising growth due to rising Prevalence of chronic back pain and potential for endoscope spinal surgery to increase the effectiveness of existin…